Form 4: Nuvalent Officer Sells Shares Under 10b5-1 Plan

Nuvalent, Inc. reports a Form 4 filing detailing stock transactions by Chief Development Officer Darlene Noci, including the sale of shares acquired via stock options under a pre-arranged trading plan.

Summary

• Darlene Noci, Chief Development Officer at Nuvalent, Inc., executed a series of stock transactions on June 29, 2026.
• These transactions involved the acquisition of 5,500 shares of Class A Common Stock at a price of $27.85 per share.
• Concurrently, 5,500 shares of Class A Common Stock were disposed of at a weighted average price of $123.51 per share, with individual sale prices ranging from $123.47 to $123.56.
• The transactions were conducted under a Rule 10b5-1 trading plan established on November 18, 2024.
• Following these transactions, Noci beneficially owns 58,117 shares of Class A Common Stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While the sale of shares by an executive can be a negative signal, the execution under a pre-arranged 10b5-1 plan mitigates concerns about opportunistic trading.

Positives

• The transactions were executed under a Rule 10b5-1 trading plan, indicating pre-planned and potentially less market-impactful sales.
• The sale price of $123.51 per share is significantly higher than the acquisition price of $27.85 for the shares acquired via options, suggesting a profitable transaction for the reporting person.

Negatives

• A significant number of shares (5,500) were sold by a key executive, which could be perceived negatively by the market.
• The sale represents a disposal of equity, reducing the reporting person's direct beneficial ownership.

Risks

• The sale of a substantial number of shares by an executive could signal a lack of confidence in future stock performance, although it was executed under a pre-arranged plan.
• The weighted average sale price indicates a range of prices, and the undertaking to provide full information upon request suggests potential scrutiny of the transaction details.

Future Outlook

The filing itself does not contain forward-looking statements or guidance regarding the company's future performance. It solely reports on past transactions by an executive.

Management Comments

• The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2024.
• The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The use of a Rule 10b5-1 plan is a common strategy for executives to diversify holdings or manage personal finances while mitigating concerns about insider trading.

Stakeholder Impact

• Shareholders: May interpret the sale as a negative signal, though the 10b5-1 plan provides context.
• Employees: May observe executive trading patterns as an indicator of company health.
• Management: The use of 10b5-1 plans is a standard practice for managing personal stock portfolios.

Next Steps

• The reporting person may continue to execute transactions under the Rule 10b5-1 plan.
• Nuvalent, Inc. or SEC staff may request further information regarding the specific sale prices.

Key Dates

Keywords

Nuvalent, NUVL, Form 4, Insider Trading, Stock Options, Rule 10b5-1, Darlene Noci, Class A Common Stock, Securities Transaction